Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.30 |
| ▸ | PRKCG | P05129 | 1/20 | 0.30 |
| ▸ | PRKCB | P05771 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 1/20 | 0.30 |
| ▸ | PRKCH | P24723 | 1/20 | 0.30 |
| ▸ | PRKCI | P41743 | 1/20 | 0.30 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.30 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.30 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.30 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.30 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6302289 | 1.00 | LMNA (0.40) | LMNAALDH1A1THRBUSP2PRKD3 | |
| SCHEMBL6310446 | 0.97 | LMNA (0.42) | LMNAALDH1A1THRB | |
| SCHEMBL23344441 | 0.92 | LMNA (0.42) | LMNAALDH1A1THRB | |
| SCHEMBL11198963 | 0.89 | USP2 (0.46) | LMNATHRBUSP2PRKD3PRKCG | |
| SCHEMBL11200004 | 0.89 | USP2 (0.46) | LMNATHRBUSP2PRKD3PRKCG | |
| SCHEMBL8912364 | 0.89 | USP2 (0.46) | LMNATHRBUSP2PRKD3PRKCG | |
| SCHEMBL11157696 | 0.89 | USP2 (0.46) | LMNATHRBUSP2PRKD3PRKCG | |
| SCHEMBL11159944 | 0.89 | USP2 (0.46) | LMNATHRBUSP2PRKD3PRKCG | |
| SCHEMBL4786370 | 0.89 | USP2 (0.46) | LMNATHRBUSP2PRKD3PRKCG | |
| SCHEMBL4786647 | 0.89 | USP2 (0.46) | LMNATHRBUSP2PRKD3PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210140060-A1 | TIN ALLOY PLATING SOLUTION | MITSUBISHI MATERIALS CORPORATION (JP) | 2021-05-13 | — | — | US | disclosed |
| WO-2020021965-A1 | TIN ALLOY PLATING SOLUTION | 三菱マテリアル株式会社 | 2020-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210140060-A1 | TIN ALLOY PLATING SOLUTION | SOS1, AP1S1, SOD1 | LMNA 4870/4885ALDH1A1 112/4885THRB 786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.